Zenotech Laboratories Limited

ZENOTECH6

INE486F01012

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:58 2024-06-14 EDT			5-day change	1st Jan Change
61.69 ^INR	+1.21%		+0.44%	-7.34%

05-17	Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024	CI
05-01	Zenotech Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Zenotech Laboratories Limited Announces Appointment of New Additional Directors

April 01, 2015 at 04:50 am

Zenotech Laboratories Ltd. appointed Smt. Kavita Shah and Mr. Vijay Agarwal as Additional Directors of the company on April 01, 2015.

Latest news about Zenotech Laboratories Limited

Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024	05-17	CI
Zenotech Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-01	CI
Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-01	CI
Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01-29	CI
Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-30	CI
Zenotech Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-04-28	CI
Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-04-28	CI
Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-27	CI
Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-10-28	CI
Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-07-22	CI
Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-04-29	CI
Sun Pharmaceutical Acquires More Stake in Zenotech Laboratories	22-03-29	MT
Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-01-28	CI
Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-10-22	CI
Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-07-24	CI
Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-05-01	CI
Zenotech Laboratories : Appoints New CEO	21-01-24	MT
Zenotech Laboratories Limited Appoints Devendra Chandrakant S. Kenkre as Chief Executive Officer	21-01-23	CI
Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	21-01-23	CI
Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	20-10-31	CI
Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	20-05-23	CI
Zenotech Laboratories Limited Announces Appointment of Directors	20-02-02	CI
Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	20-02-01	CI
Zenotech Laboratories Limited Appoints Rakeshchandra Jagdishprasad Sinha as Non- Executive and Non-Independent	20-02-01	CI
Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	19-11-04	CI

Chart Zenotech Laboratories Limited

Duration

Period

More charts

Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.

Sector

Pharmaceuticals

Calendar

2024-07-31 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ZENOTECH LABORATORIES LIMITED	-7.34%	45.07M
NOVO NORDISK A/S	+41.96%	630B
JOHNSON & JOHNSON	-7.15%	350B
MERCK & CO., INC.	+18.77%	328B
ABBVIE INC.	+8.79%	298B
ASTRAZENECA PLC	+18.02%	246B
ROCHE HOLDING AG	+1.27%	225B
NOVARTIS AG	+11.95%	218B
AMGEN INC.	+3.68%	160B
PFIZER, INC.	-4.38%	156B